Literature DB >> 29950604

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.

Alexander C Ford1, Paul Moayyedi2, William D Chey3, Lucinda A Harris4, Brian E Lacy5, Yuri A Saito6, Eamonn M M Quigley7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29950604     DOI： 10.1038/s41395-018-0084-x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  60 in total

1.  Highlights of the Updated Evidence-Based IBS Treatment Monograph.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-11

Review 2.  The gut microbiome: what every gastroenterologist needs to know.

Authors:  Benjamin H Mullish; Mohammed Nabil Quraishi; Jonathan P Segal; Gianluca Ianiro; Tariq H Iqbal
Journal:  Frontline Gastroenterol       Date:  2020-02-04

3.  Update on Irritable Bowel Syndrome Guidelines.

Authors:  Brian E Lacy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 4.  The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.

Authors:  Quentin Le Bastard; Guillaume Chapelet; François Javaudin; Didier Lepelletier; Eric Batard; Emmanuel Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

5.  Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?

Authors:  Khadijeh Abhari; Saeede Saadati; Fatemeh Hosseini-Oskouiee; Zahra Yari; Hedayat Hosseini; Golbon Sohrab; Ehsan Hejazi; Shahram Agah; Amir Sadeghi; Azita Hekmatdoost
Journal:  Eur J Nutr       Date:  2019-07-20       Impact factor: 5.614

Review 6.  Evidence-based and mechanistic insights into exclusion diets for IBS.

Authors:  Paul Moayyedi; Magnus Simrén; Premysl Bercik
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-02       Impact factor: 46.802

7.  Management of functional gastrointestinal disorders.

Authors:  Asma Fikree; Peter Byrne
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

8.  Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors:  Eric D Shah; Sameer D Saini; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-01       Impact factor: 11.382

Review 9.  Best management of irritable bowel syndrome.

Authors:  Christopher J Black; Alexander Charles Ford
Journal:  Frontline Gastroenterol       Date:  2020-05-28

10.  Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome.

Authors:  Christopher V Almario; Samuel Eberlein; Carine Khalil; Brennan M R Spiegel
Journal:  Neurogastroenterol Motil       Date:  2021-04-02       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.